No Data
Kangtuo Medical (688314.SH): Personalized polyether ether ketone skull defect repair prosthesis obtained medical instrument registration certificate.
Concord Medical (688314.SH) announced that the company recently obtained the third pharmaceutical product...
Kangtuo Healthcare: Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the Third Quarter of 2024
Xi\'an Kangtuo Medical Technology Co., Ltd. Report for the Third Quarter of 2024
Kangtuo Medical (688314.SH) released its performance for the first three quarters, with a net income of 76.71 million yuan, a year-on-year increase of 19.22%.
Kangtuo Medical (688314.SH) disclosed the third quarter report of 2024, achieving a revenue of 2...
Kangtuo Medical (688314.SH): The net income in the first three quarters is about 76.71 million yuan, an increase of 19.22% year-on-year.
Kangtuo Medical (688314.SH) announced on October 28 that its revenue in the first three quarters of 2024 was approximately 0.24 billion yuan, an increase of 16.22% year-on-year; the net income attributable to shareholders of the listed company was approximately 76.71 million yuan, an increase of 19.22% year-on-year; and the basic earnings per share was 0.94 yuan.
Konat medical (688314.SH): The work of localizing the production of PEEK material bone plates in the United States is still steadily progressing, and it is expected to achieve on-site production by 2024.
Gelonghui, August 21st | Kantor Medical (688314.SH) stated on the investor interaction platform that the overall machining and surface treatment of BIOPLATE titanium materials at its US subsidiary has now been transferred to domestic factories. The work on the localization production of PEEK material bone plates in the USA is still steadily progressing and is expected to be achieved by 2024.
No Data
No Data